Focused on restoring vision for people with blindness, Nanochap has pioneered a dual-pathway strategy for high-resolution artificial vision: E-BCI, an electronic retinal implant, and V-BCI, an implant targeting the visual cortex. Together, these complementary technologies aim to address a broad range of vision-loss conditions. The company has already successfully developed multiple products, including high-density neural stimulation chip, continuous biomolecular signal detection chips, EEG detection chips, and programmable neural stimulation chips, with key chip performance metrics reaching internationally leading levels.